The trajectory of companies tied to Viagra's past presents a complex investment landscape. While the initial surge generated substantial profits , generic copies have significantly impacted sales . Investing in connected pharmaceutical companies now requires a thorough assessment of patent safeguards, evolving patient trends , and the potential for